Skip to content

Medical-device intelligence

PRI: Procalcitonin Assay

FDA product code PRI: Procalcitonin Assay. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
PRI
FDA device name
Procalcitonin Assay
Device class
2
Regulation number
866.3215
Medical specialty
Microbiology
Review panel
MI

FDA definition

To aid in decision making on antibiotic therapy, including antibiotic initiation and discontinuation, for inpatients or patients in the Emergency Department, with suspected or confirmed lower respiratory tract infections (LRTI) defined as community-acquired pneumonia (CAP), acute bronchitis, and acute exacerbation of Chronic Obstructive Pulmonary Disease (AECOPD).
Explore microbiology records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

8 clearance records and 1 recall records in the covered releases, across 7 source company names and 1 product codes. Dated history runs from Feb 23, 2017 to Aug 26, 2022.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

Code and FDA device nameClearancesRecalls
PRI · Procalcitonin Assay81

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

9 matching records
Device / recordCompany in FDA recordSourceSource date
Dimension EXL LOCI BRAHMS Procalcitonin (PCT)K220262 · PRISiemens Healthcare Diagnostics, Inc.510(k)Aug 26, 2022FDA decision date
VIDAS B.R.A.H.M.S. PROCALCITONIN PCT, REF 30450-01Z-0428-2022 · PRIbioMerieux, Inc.RecallDec 28, 2021FDA record creation date
Elecsys BRAHMS PCTK192815 · PRIRoche Diagnostics510(k)Mar 9, 2020FDA decision date
Elecsys BRAHMS PCTK173927 · PRIRoche Diagnostics510(k)Jul 6, 2018FDA decision date
LIAISON BRAHMS PCT II GEN, LIAISON Control BRAHMS PCT II GEN, LIAISON BRAHMS PCT II GEN VerifiersK173683 · PRIDiaSorin, Inc.510(k)Feb 27, 2018FDA decision date
Lumipulse G B•R•A•H•M•S PCT Immunoreaction Cartridges, Lumipulse G B•R•A•H•M•S PCT Calibrators setK172713 · PRIFujirebio Diagnostics,Inc.510(k)Dec 10, 2017FDA decision date
ARCHITECT B.R.A.H.M.S PCT, ARCHITECT B.R.A.H.M.S PCT Calibrators, ARCHITECT B.R.A.H.M.S PCT ControlsK170652 · PRIFisher Diagnostics510(k)Jun 1, 2017FDA decision date
B R A H M S PCT sensitive KRYPTORK171338 · PRIBrahms GmbH510(k)May 31, 2017FDA decision date
VIDAS B.R.A.H.M.S. PCT (PCT)K162827 · PRIbioMerieux, Inc.510(k)Feb 23, 2017FDA decision date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 21, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗